Harmony Biosciences Holdings, Inc. (HRMY)
Sector: Pharmaceutical Preparations
Industry: Biotechnology
Harmony Biosciences Holdings, Inc.
NASDAQ:HRMYHealthcare · Biotechnology
+1.97%$33.11
CLOSED · Nov 6Prev close$32.47+1.97%Close$33.11-0.33%AH close$33.00
AH$33.00-0.33%vs close
Mkt Cap$1.94B
Float45.73M
O/S58.72M
VOL787K sh
$ Vol$26M
RVOL0.64×
Inst Own96.0%
SI11.8%
Dilution
Historical Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 6, 2026 | 32.70 | 33.38 | 32.27 | 33.11 | 787,174 |
| Nov 5, 2026 | 35.68 | 35.68 | 32.30 | 32.47 | 1,477,534 |
| Nov 4, 2026 | 34.50 | 35.97 | 32.61 | 34.41 | 2,469,409 |
| Nov 3, 2026 | 37.97 | 38.75 | 36.33 | 37.02 | 1,445,202 |
| Nov 2, 2026 | 38.77 | 39.03 | 37.69 | 37.91 | 993,981 |
| Oct 30, 2026 | 38.58 | 39.10 | 38.39 | 38.76 | 871,474 |
| Oct 29, 2026 | 38.65 | 39.20 | 38.04 | 38.59 | 778,849 |
| Oct 28, 2026 | 37.72 | 38.52 | 37.28 | 38.50 | 1,002,759 |
| Oct 27, 2026 | 36.90 | 37.98 | 36.62 | 37.95 | 736,932 |
| Oct 26, 2026 | 36.28 | 37.19 | 36.13 | 36.83 | 852,697 |
| Oct 23, 2026 | 36.11 | 37.05 | 35.00 | 36.13 | 2,313,565 |
| Oct 22, 2026 | 38.50 | 39.63 | 34.11 | 36.03 | 2,905,502 |
| Oct 21, 2026 | 38.58 | 38.93 | 38.13 | 38.31 | 1,062,533 |
| Oct 20, 2026 | 37.99 | 39.23 | 37.49 | 38.70 | 798,586 |
| Oct 19, 2026 | 37.84 | 37.97 | 37.16 | 37.54 | 1,008,467 |
| Oct 16, 2026 | 38.47 | 39.00 | 37.85 | 37.95 | 892,270 |
| Oct 15, 2026 | 38.04 | 39.00 | 38.00 | 38.27 | 798,333 |
| Oct 14, 2026 | 37.16 | 38.31 | 36.92 | 37.51 | 972,241 |
| Oct 13, 2026 | 37.91 | 38.17 | 35.99 | 37.03 | 1,419,022 |
| Oct 12, 2026 | 38.34 | 39.89 | 37.01 | 38.23 | 1,148,359 |
Analyst Coverage
Analyst Coverage
ConsensusBuy
Price Target (median, last 90d)
$60.00+81.2%
Low $60High $60
Ratings Distribution
BUY8
HOLD3
SELL2
TOTAL13
Insider Trades
| Insider | Title | Type | Shares | Value | Date |
|---|---|---|---|---|---|
 Budur Kumar | CHIEF MEDICAL OFFICER | Option Exercise | 25.4K | -- | Sep 18, 2026 |
| Budur Kumar | CHIEF MEDICAL OFFICER | Option Exercise | 25.4K | $770.3K | Sep 18, 2026 |
| Budur Kumar | CHIEF MEDICAL OFFICER | Sale | 35.9K | $1.54M | Sep 18, 2026 |
| Budur Kumar | CHIEF MEDICAL OFFICER | Option Exercise | 10.4K | $319.4K | Sep 18, 2026 |
| Budur Kumar | CHIEF MEDICAL OFFICER | Option Exercise | 10.4K | -- | Sep 18, 2026 |
| Budur Kumar | CHIEF MEDICAL OFFICER | Option Exercise | 400 | $12.3K | Sep 17, 2026 |
Shareholders
96.0%
Institutional
(351)
11.4%
Insiderⓘ
(8)
10.3%
5%+ Owners
(1)
-
Unattributed (incl. retail)ⓘ
Institutional96.0%
Insider11.4%
5%+ Beneficial10.3%
Top Shareholders
| Name | Shares | % | Source |
|---|---|---|---|
BlackRock, Inc. · also on 13F· may incl. warrants· filed Oct 2026 | 7.4M | 12.5% | 13G |
BlackRock, Inc. | 7.1M | 12.1% | 13F |
 Valor IV Pharma Holdings, LLC 10% Owner | 6.6M | 11.3% | FORM 4 |
Marshman Fund Trust II · may incl. warrants· filed Feb 2025 | 6.1M | 10.3% | 13G |
FMR LLC · also on 13F· may incl. warrants· filed Feb 2024 | 5.3M | 9.0% | 13G |
FMR LLC | 3.6M | 6.1% | 13F |
VANGUARD PORTFOLIO MANAGEMENT LLC | 2.9M | 4.9% | 13F |
DIMENSIONAL FUND ADVISORS LP | 2.6M | 4.5% | 13F |
AMERICAN CENTURY COMPANIES INC | 2.5M | 4.3% | 13F |
LSV ASSET MANAGEMENT | 2.2M | 3.8% | 13F |
Sources: 13F, Form 4, 13D/13GO/S: 58.7M · as of 2 Nov 2026 · SEC cover page
Insiders & Institutional Holders
Insiders
- Budur KumarCHIEF MEDICAL OFFICER
- Sender GaryDirector
- Germano Geno JDirector
- Szyper Linda MDirector
- Sabater Juan A.Director
- Graf R. MarkDirector
- Philip Ron MDirector
- Reicin GlennCHIEF FINANCIAL OFFICER
- Zaeske Adam H.CHIEF COMMERCIAL OFFICER
- Ignelzi Troy A.Director
About
Harmony Biosciences Holdings, Inc. is a commercial-stage pharmaceutical firm dedicated to developing and marketing therapies for individuals in the United States who suffer from rare neurological conditions. Their flagship product, WAKIX, is a prescription medication designed to treat excessive daytime sleepiness in adult patients diagnosed with narcolepsy.
The company, which was founded in 2017, was formerly known as Harmony Biosciences II, Inc. before adopting its current name in February 2020. Harmony Biosciences Holdings, Inc. operates out of Plymouth Meeting, Pennsylvania.
Key Metrics
Market Cap$1.94B
Enterprise Value--
P/E Ratio--
Est. Net Cash/Share--
Institutional Ownership95.97%
based on 58.72M shares outstanding
SectorHealthcare
IndustryBiotechnology
ExchangeNASDAQ
Country
US
USIPO DateAug 19, 2020
Shares Outstanding58.72M
Authorized Shares
Float45.73M
52-Week Range
$25.90$43.49
$33.11(41st percentile)
Volume
Average Daily Volume1.24M
787.17K today vs 1.24M avg(-36%)
30d Avg
1.24M
60d Avg
1.12M
90d Avg
989.50K
Earnings
Dividend History
No dividend history available
Compliance Status
Loading compliance data...